HealthCare Royalty Partners Names Former Janney Investment Banking Head Christopher White to COO
STAMFORD, CT – December 10, 2014 – HealthCare Royalty Partners (“HC Royalty”) today announced it has named Christopher A. White as Chief Operating Officer, a newly established senior management position. Mr. White will oversee all non-investment operations for the firm including legal, compliance, finance and investor services. He most recently served as Managing Director and Head of Investment Banking at Janney Montgomery Scott LLC (“Janney”). His appointment is effective December 18, 2014.
“Chris is a seasoned industry executive with an exceptional operational background. We had the opportunity to work side-by-side with him for several years as he served on both our investment and operating committees. Chris understands our business and will be a tremendous asset as we deploy Fund III and look to continue to build the firm in the coming years,” commented Gregory B. Brown, M.D., Founding Managing Director at HC Royalty.
Mr. White has over twenty years of legal, financial and operational experience. While at Janney, he was responsible for leading the strategic direction, business development and corporate finance activities of the Investment Banking Division within the Capital Markets Group. Prior to joining Janney in 2011, Mr. White spent over a decade at Cowen Group, Inc. where he held a number of senior management positions including Chief Administrative Officer, Chief Financial Officer and Chief Operating Officer. Mr. White previously served in senior leadership positions at Salomon Smith Barney and spent seven years as a securities and mergers and acquisitions lawyer. He earned his undergraduate degree from Amherst College and J.D. from the University of Michigan Law School.
“Greg, Todd and Clarke are smart, innovative and committed to producing non-correlated absolute returns for their investors. They have built a significant business over the past few years and I am honored to re-join them as the firm enters its next stage of growth,” commented Chris White.
In October 2014, HC Royalty announced the closing on $1.5 billion for HealthCare Royalty Partners III, L.P. and affiliated entities. This follows the $1 billion closing of HealthCare Royalty Partners II, L.P. and affiliated entities in December 2011 and the closing of its inaugural $500 million fund, HealthCare Royalty Partners, L.P. in July 2008.
About HealthCare Royalty Partners
HealthCare Royalty Partners (HC Royalty) is a $3.0+ billion global healthcare investment firm. HC Royalty invests primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the world’s largest pharmaceutical companies. Over the past decade, the senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
# # #